Researchers looked into the existing literature regarding the long coronavirus disease (COVID) in a recent review that was published in Nature Reviews Microbiology. They talked about important immunological findings, symptoms that are similar to those of other diseases, associated pathophysiological mechanisms, and diagnostic and therapeutic options, like COVID-19 vaccinations.
Long COVID is a multisystem disease that affects people who are positive for SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) and is getting more common by the day. There are increasing similarities between long COVID and other diseases like POTS (postural orthostatic tachycardia syndrome) and ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) that have been reported in studies on risk factors, symptoms, pathophysiology, diagnosis, and treatment options.
About the review: The researchers looked at the data on long COVID immunology, symptoms, pathophysiology, diagnosis, and treatment options in the current review.
PD1 (programmed cell death protein-1) expression has been found to be elevated and exhausted T lymphocytes, dendritic cells, cluster of differentiation 4+ (CD4+) lymphocyte, and CD8+ lymphocyte counts have been found to be consistently lower in COVID patients. Non-classical monocytes, an increase in the expression of interleukins (IL)-1, 4, and tumor necrosis factor (TNF), and an increase in innate cell immunological activities. A persistent increase in CCL11 (C-X-C motif chemokine 11) expression has been linked to cognitive dysfunction in long COVID patients, and cytotoxic T lymphocyte expansion has been linked to gastrointestinal symptoms.
Autoantibodies against ACE2 (angiotensin-converting enzyme 2), angiotensin II receptor type I (AT1) receptors, 2-adrenoceptors, angiotensin 1–7 Mas receptors, and muscarinic M2 receptors have been found to be elevated in long COVID patients. In long-term COVID patients and ME/CFS, reactivation of Epstein-Barr virus (EBV) and human herpes virus 6 (HHV-6) has been reported. In long-term COVID, EBV reactivation has been linked to cognitive impairments and fatigue.
Long-lasting COVID symptoms are reportedly caused by SARS-CoV-2 persistence. In addition to serum, breast fluid, urine, and stool from long-term COVID patients, SARS-CoV-2 proteins and/or ribonucleic acid (RNA) have been found in cardiovascular, reproductive, cranial, ophthalmic, muscular, lymphoid, hepatic, and pulmonary tissues. ME/CFS and long COVID share similar immunological patterns, with elevated cytokine levels during the first two to three years of the disease and subsequent decline over time without symptomatic improvement. Endometriosis, changes in menstruation, and intestinal dysbiosis occur in both conditions, as do lower cortisol levels, mitochondrial dysfunction, post-exercise malaise, dysautonomia, mast cell activation, platelet hyperactivation, and hypermobility.
Long COVID symptoms and underlying pathophysiological mechanisms Antibodies eBook Industry Focus eBook A compilation of the most important interviews, articles, and news from the previous year.
Long-term COVID-associated organ damage is said to be caused by COVID-19-induced inflammation and immune responses. Endothelial dysfunction, microclotting, and decreased vascular density have been linked to cardiovascular long COVID symptoms like chest pain and palpitations. Long-term COVID has been linked to an increased risk of type 2 diabetes and kidney damage. The loss of small corneal nerve fibers, increased dendritic cell density, and impaired retinal microvasculature all contribute to the ophthalmic symptoms of long COVID, which include altered pupillary responses to light. Alterations in pulmonary perfusion, epithelial injury, and air entrapment in the airways are the causes of respiratory symptoms like a persistent cough and difficulty breathing.
Memory loss, cognitive decline, difficulty sleeping, paresthesia, difficulty balancing, sensitivity to light and noise, tinnitus, and loss of taste or smell are some of the cognitive and neurological long COVID symptoms. Kynurenine pathway activation, endothelial injury, coagulopathy, lower cortisol levels, loss of myelin, microglial reactivation, oxidative stress, hypoxia, and tetrahydrobiopterin deficiency are among the underlying pathophysiological mechanisms. Increased Bacteroides vulgatus and Ruminococcus gnavus counts and decreased Faecalibacterium prausnitzii counts have been linked to gastrointestinal symptoms like pain in the abdomen, nausea, loss of appetite, constipation, and heartburn. The onset of neurological symptoms is typically delayed, they get worse over time, and they last longer than respiratory or gastrointestinal symptoms. Both children and adults with long COVID present with the same symptoms.
Options for long-term COVID diagnosis and treatment, including COVID-19 vaccines Tilt tests for POTS, magnetic resonance imaging (MRI) to detect impairments in the cardiovascular and pulmonary systems, and electrocardiograms to detect QRS complex fragmentation are all symptom-based methods of diagnosing and treating long-term COVID. Immunological biomarker levels can be assessed through salivary and serological tests, such as red blood cell deformation, lipid profile, complete blood count, D-dimer, and C-reactive protein (CRP) evaluations. Antibody testing is used to evaluate humoral immune responses against SARS-CoV-2, and PCR (polymerase chain reaction) analysis is used to detect and quantify SARS-CoV-2 RNA.
Intravenous Ig for immune dysfunction, low-dose naltrexone for neuronal inflammation, beta-blockers for POTS, anticoagulants for the formation of microclots, and stellate ganglion blockade for dysautonomia are examples of pharmaceutical treatments. Paxlovid, sulodexide, antihistamines, and pycnogenol are additional options. Cognitive pacing for cognitive impairments, restricting one's diet for gastrointestinal symptoms, and increasing one's salt intake for POTS are examples of non-pharmacological treatments. The development of long COVID is influenced by the causative SARS-CoV-2 variant and the number of vaccination doses received, so COVID-19 vaccines have only provided minimal protection. Post-SARS-CoV-2 Omicron BA.2 subvariant infections, longer COVID infections have been reported more frequently.
The findings of the review indicate that long COVID is a multiorgan disease with inadequate diagnostic and therapeutic options that has claimed a number of lives worldwide. In order to lessen the burden of long COVID in the future, additional research, clinical trials, education enhancements, campaigns of mass communication, funding, and policies are required.
You must be logged in to post a comment.